Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 160,309 | 173,030 | 191,328 | 194,385 | 200,104 |
| Receivables | 4,172 | 3,486 | 3,441 | 10,388 | 10,269 |
| TOTAL | $171,065 | $184,777 | $200,665 | $213,041 | $218,621 |
| Non-Current Assets | |||||
| PPE Net | 12,269 | 13,741 | 12,712 | 7,957 | 6,766 |
| Intangibles | 38,107 | 38,897 | 39,688 | 40,478 | 41,689 |
| Other Non-Current Assets | 8,529 | 8,713 | 8,751 | 8,729 | 8,405 |
| TOTAL | $58,905 | $61,351 | $61,151 | $57,164 | $56,860 |
| Total Assets | $229,970 | $246,128 | $261,816 | $270,205 | $275,481 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,145 | 2,429 | 4,327 | 3,748 | 2,411 |
| Accrued Expenses | 11,923 | 8,547 | 7,012 | 8,061 | 11,323 |
| TOTAL | $18,569 | $12,111 | $11,988 | $12,242 | $14,031 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 111 |
| Other Non-Current Liabilities | 14,315 | 14,483 | 13,072 | 10,990 | 11,639 |
| TOTAL | $15,798 | $16,555 | $16,259 | $14,762 | $17,298 |
| Total Liabilities | $34,367 | $28,666 | $28,247 | $27,004 | $31,329 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,565 | 38,525 | 38,370 | 38,339 | 37,297 |
| Common Shares | 87 | 87 | 87 | 95 | 95 |
| Retained earnings | -159,297 | -145,225 | -121,423 | -103,243 | -82,054 |
| Other shareholders' equity | -30,894 | -23,036 | -28,618 | -33,155 | -50,828 |
| TOTAL | $195,603 | $217,462 | $233,569 | $243,201 | $244,152 |
| Total Liabilities And Equity | $229,970 | $246,128 | $261,816 | $270,205 | $275,481 |